BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 25459400)

  • 1. Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting.
    Genton L; Cani PD; Schrenzel J
    Clin Nutr; 2015 Jun; 34(3):341-9. PubMed ID: 25459400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle wasting: the gut microbiota as a new therapeutic target?
    Bindels LB; Delzenne NM
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2186-90. PubMed ID: 23831839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human gut microbiota: Metabolism and perspective in obesity.
    Gomes AC; Hoffmann C; Mota JF
    Gut Microbes; 2018 Jul; 9(4):308-325. PubMed ID: 29667480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and the development of obesity.
    Boroni Moreira AP; Fiche Salles Teixeira T; do C Gouveia Peluzio M; de Cássia Gonçalves Alfenas R
    Nutr Hosp; 2012; 27(5):1408-14. PubMed ID: 23478685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and obesity: lessons from the microbiome.
    Cani PD
    Brief Funct Genomics; 2013 Jul; 12(4):381-7. PubMed ID: 23616309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Gut Microbiota in the development of obesity and Diabetes.
    Baothman OA; Zamzami MA; Taher I; Abubaker J; Abu-Farha M
    Lipids Health Dis; 2016 Jun; 15():108. PubMed ID: 27317359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microorganisms as promising targets for the management of type 2 diabetes.
    Delzenne NM; Cani PD; Everard A; Neyrinck AM; Bindels LB
    Diabetologia; 2015 Oct; 58(10):2206-17. PubMed ID: 26224102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota composition and its effects on obesity and insulin resistance.
    Caricilli AM; Saad MJ
    Curr Opin Clin Nutr Metab Care; 2014 Jul; 17(4):312-8. PubMed ID: 24848531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.
    Musso G; Gambino R; Cassader M
    Annu Rev Med; 2011; 62():361-80. PubMed ID: 21226616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the role of gut microbiome in metabolic disease risk.
    Sanz Y; Olivares M; Moya-Pérez Á; Agostoni C
    Pediatr Res; 2015 Jan; 77(1-2):236-44. PubMed ID: 25314581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota in obesity and metabolic disorders.
    Sanz Y; Santacruz A; Gauffin P
    Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota, nutrient sensing and energy balance.
    Duca FA; Lam TK
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():68-76. PubMed ID: 25200299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.